FIELD: chemistry.
SUBSTANCE: invention relates to a process of obtaining SGLT2 benzylenbenzole inhibitors, producing an inhibitory effect on sodium-dependent glucose transporter of compound of formula , comprising (a) production of the first reaction mixture, containg formula : alkyl magnesium complex selected from groups, consisting of C1-C4 alkyl magnesium chloride, C1-C4 alkyl magnesium bromide, (C1-C4 alkyl) dimagnesium, C3-C7 cycloalkylmagnesium chloride, C3-C7 cycloalkylmagnesium bromide and (C3-C7 cycloalkyl) dimagnesium and the first organic solvent, where proportion of alkil magnesium complex and the compound of formula IIa is selected from 0.9, 0.91, 0.92, 0.93, 0.94, 0.95, 0.96 and 0.97 (mmol/mmol), where the first reaction mixture is at a temperature of -50°C or lower, with formation of an intermediate compound; and (b) production of the second reaction mixture containing an intermediate compound, a second organic solvent and a compound of formula IIIa: with formation of compound of formula Ia where R4 is OH and each Ra is Rb; (C) obtaining the third reaction mixture containing C1-C3 alkyl hydroxy, a strong acid and a compound of formula Ia where R4 is OH and each Ra is Rb, with formation of a compound of formula Ia where R4 is C1-C3 alkoxy, and each Ra is independently seleted from the group, containg H and Rb; and (d) obtaining of the fourth reaction mixture, comprising a reducing agent and a compound of formula Ia where R4 is C1-C3 alkoxy and where the reaction mixture contains less than 0.1 magnesium equivalents in relation to quantity of compound of formula Ia with formation of a compound of formula Ia, where R4 is H, where X is iodine, R1 is chlorine, R2 is H, R3 is (C3-C6 cycloalkoxy) C1-C3 alkoxy, R4 is selected from the group consisting of H, OH and C1-C3 alkoxy, each R4 is independently selected from the group, consisting of H, C1-C3 alkyl and Rb. Rb is a protection group, where alkyl, alkoxy and cycloalkyl groups or their parts can optionally be completely or partially fluorinated and one or more hydrogen atoms may optionally be replaced with deuterium atoms and synthetic intermediates which can be used for obtaining such compounds. .
EFFECT: increase the output of desired product and decrease the amount of by-products.
38 cl, 2 tbl, 7 dwg, 25 ex
Title | Year | Author | Number |
---|---|---|---|
CRYSTALLINE FORMS OF COMPLEXES USEFUL AS SGLT2 INHIBITORS, AND METHODS OF THEIR OBTAINING | 2014 |
|
RU2641905C2 |
METHOD OF PRODUCING SGLT2 INHIBITORS | 2009 |
|
RU2530494C2 |
INTERMEDIATE USED FOR SYNTHESIS OF SGLT INHIBITOR AND METHOD FOR PRODUCING SGLT INHIBITOR USING THIS INTERMEDIATE | 2021 |
|
RU2802443C1 |
CRYSTALLINE FORM OF BENZYL-BENZENE SGLT INHIBITOR | 2011 |
|
RU2569491C2 |
C-ARYL GLUCOSIDE DERIVATIVES, PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF | 2011 |
|
RU2606501C2 |
BENZYLPHENYLCYCLOHEXANE DERIVATIVES AND METHODS OF THEREOF APPLICATION | 2008 |
|
RU2505521C2 |
BENZYL BENZENE DERIVATIVES AND METHODS FOR USING THEM | 2008 |
|
RU2497526C2 |
METHOD FOR PRODUCING DEPHENYLMETHANE DERIVATIVE | 2017 |
|
RU2797392C2 |
PREPARATION OF HYDROXY-BENZYLBENZENE DERIVATIVES | 2014 |
|
RU2671493C2 |
METHOD OF PRODUCING DEPHENYLMETHANE DERIVATIVE | 2023 |
|
RU2814846C1 |
Authors
Dates
2017-07-19—Published
2013-03-14—Filed